Barrington Strategic Wealth Management Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$892K Sell
10,037
-5
-0% -$381 0.45% 59
2017
Q2
$728K Sell
10,042
-88
-0.9% -$5.92K 0.37% 69
2017
Q1
$660K Sell
10,130
-470
-4% -$29.5K 0.34% 76
2016
Q4
$664K Sell
10,600
-20
-0.2% -$1.22K 0.36% 74
2016
Q3
$670K Sell
10,620
-4,790
-31% -$310K 0.38% 70
2016
Q2
$954K Sell
15,410
-305
-2% -$18.6K 0.55% 51
2016
Q1
$898K Sell
15,715
-335
-2% -$18.7K 0.52% 52
2015
Q4
$951K Sell
16,050
-326
-2% -$18.8K 0.56% 49
2015
Q3
$891K Sell
16,376
-235
-1% -$15.3K 0.57% 52
2015
Q2
$1.12M Buy
16,611
+110
+0.7% +$7.18K 0.67% 50
2015
Q1
$966K Buy
16,501
+746
+5% +$45.1K 0.59% 55
2014
Q4
$1.03M Buy
15,755
+740
+5% +$46.7K 0.66% 51
2014
Q3
$867K Buy
15,015
+446
+3% +$24.8K 0.56% 58
2014
Q2
$822K Buy
14,569
+204
+1% +$10.7K 0.52% 60
2014
Q1
$738K Buy
14,365
+633
+5% +$32K 0.48% 64
2013
Q4
$725K Sell
13,732
-74
-0.5% -$3.64K 0.48% 62
2013
Q3
$618K Buy
13,806
+2,110
+18% +$93.5K 0.55% 57
2013
Q2
$484K Buy
+11,696
New +$512K 0.4% 71

Other funds holding ABBV

Barrington Strategic Wealth Management Group's ABBV Position: Q3 2017 in Review

Barrington Strategic Wealth Management Group reduced its AbbVie (ABBV) stake by 0.05% in Q3 2017, selling an estimated $381 and leaving 10,037 shares worth $892K. The position accounts for 0.45% of the portfolio, ranked #59.

Barrington Strategic Wealth Management Group first reported a position in ABBV in Q2 2013 and has held it in 18 quarters since. The position peaked at $1.12M in Q2 2015. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.

  • Barrington Strategic Wealth Management Group held 10,037 shares of AbbVie worth $892K as of Q3 2017.
  • Barrington Strategic Wealth Management Group sold 5 AbbVie shares in Q3 2017, an estimated $381.
  • AbbVie made up 0.45% of Barrington Strategic Wealth Management Group's portfolio in Q3 2017, its #59 holding.
  • Barrington Strategic Wealth Management Group first reported a position in AbbVie in Q2 2013 and has held it in 18 quarters since.
  • Barrington Strategic Wealth Management Group's AbbVie position peaked at $1.12M in Q2 2015.
  • 1,797 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.

Based on Barrington Strategic Wealth Management Group's 13F filing for Q3 2017, filed 31 Oct 2017.